Pfizer Asks FDA To Authorize Its Merck-Rivaling Covid Pill

 Pfizer stock inched higher Tuesday after the company asked the Food and Drug Administration to authorize its Covid pill for emergency use.

The two-pill regimen, dubbed Paxlovid, could be the first in its class to gain authorization. Merck (MRK) also has an oral antiviral under FDA review, but it uses a different mechanism to fight the virus that causes Covid.

https://www.investors.com/news/technology/pfizer-stock-drug-giant-asks-fda-to-authorize-its-merck-rivaling-covid-pill/